Mirxes outlines roadmap to resume trading after US$14.00 million prepayment probe stalls FY2025 audit

Bulletin Express
04/30

Mirxes Holding Company Limited reported that the Hong Kong Stock Exchange (HKEX) has issued six specific resumption conditions following the suspension of its shares on 1 April 2026.

Key resumption requirements 1. Independent forensic investigation: Mirxes must complete and disclose an investigation into fourteen prepayments totaling approximately US$14.00 million made in FY2025, related post-year-end cash outflows, and any similar transactions, and implement remedial actions. 2. Management integrity: The company must prove no regulatory concerns exist regarding senior executives or influential parties. 3. Internal controls: An external consultant must confirm all material control deficiencies have been rectified and that Listing Rule compliance procedures are effective. 4. Financial reporting: All outstanding results must be published and any audit modifications addressed. 5. Listing Rule 13.24 compliance: Mirxes must demonstrate it has a viable business and sufficient operations. 6. Market disclosure: Full disclosure of all information material to investors is required.

Delisting clock and reporting obligations • Under Rule 6.01A(1), HKEX may cancel the listing if trading is not resumed within 18 months; Mirxes faces a hard deadline of 30 September 2027. • Quarterly progress updates are mandatory, with the first report due by 1 July 2026.

Audit triggers for suspension KPMG, the group’s auditor, delayed signing off FY2025 accounts after flagging: • Fourteen prepayments to multiple vendors amounting to US$14.00 million. • Insufficient evidence on the commercial rationale, vendor relationships, procurement compliance and pricing of those prepayments. • “Material” post-31 December 2025 cash outflows whose business purpose remains unverified.

Governance measures • An Independent Investigation Committee (IIC) is overseeing the forensic review and will seek KPMG’s validation that findings fully address audit issues. • Somerley Capital Limited continues as compliance adviser throughout the remedial period.

Trading status Mirxes shares remain suspended; any further updates will be disclosed in accordance with Listing Rules. Investors are advised to exercise caution when dealing in the company’s securities.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10